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A B S T R A C T
Over the recent years it has become clear that reperfusion by primary coronary in-
tervention in patients with ST elevation myocardial infarction (STEMI) is superior 
to thrombolytic therapy and is the treatment of choice. However, this reperfusion 
strategy has some drawbacks, as cardiac catheterization laboratories are not always 
widely available 24 hours/7 days and long- time delays related to primary percuta-
neous coronary intervention (pPCI) could have negative impact on mortality. The 
shorter the delay from symptom onset to reperfusion, the greater the amount of the 
myocardium rescued as it is obvious that “time is muscle”. Among pPCI related times 
the crucial time delay is the “door–to-balloon time”, which is the time from arrival at 
the hospital until the mechanical restoration of the vessel patency. This time delay is 
usually accurately recorded and depends on the national (or even local) health care 
system. The European Society of Cardiology guidelines on myocardial revasculariza-
tion suggest that total ischemic time should not exceed 120 min and especially 90 
min for patients <65 years old, with anterior infarction and early presentation (<2 
hours) from onset of symptoms, because these categories of patients have even worse 
outcomes and increased mortality with prolonged door-to-balloon times, compared 
to other categories.
Better education of the patient about symptoms suggesting myocardial ischemia, 
pre-hospital diagnosis of STEMI based on 12-lead electrocardiogram with immedi-
ate transportation to a PCI-capable center in order to eliminate inter-hospital delays, 
an effective emergency medical system capable of quick transportation, immediate 
activation of the cardiac catheterization laboratory from emergency physicians or an 
attendant cardiologist, the presence of an experienced team of high volume opera-
tors and skilled supporting staff capable of performing PPCI 24 hours/7 days, new 
and more effective antithrombotic drugs and angioplasty materials, are the key ele-
ments to achieve shorter door-to-balloon and PCI delay times and therefore to save 
the greatest amount of myocardium and reduce mortality.
I N T R O D U C T I O N
Recently published results from several trials (DANAMI-2,1 PRAGUE-1,2 and 
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-23, AIR -PAMI4 which compared on site thrombolysis with 
primary PCI (defined as angioplasty and/or stenting without 
prior or concomitant fibrinolytic therapy), showed that pri-
mary PCI (pPCI) is the cornerstone for effective treatment of 
ST-elevation myocardial infarction (STEMI) patients, when 
it can be performed by an experienced team. Combined data 
from those trials put emphasis on the superiority of pPCI in 
significantly decreasing the composite endpoint of nonfatal 
myocardial infarction, stroke or death compared to fibrinoly-
sis.5 Primary PCI is associated with more effective restoration 
of vessel patency, less re-occlusion, improved residual left 
ventricular function and better clinical outcome.6 However, 
the need for an experienced team including not only interven-
tional cardiologists, but also skilled supporting staff available 
24 hours/7 days in combination with an emergency medical 
system (EMS) capable of establishing quick diagnosis and fast 
transportation (within acceptable time limits) to a PCI–capable 
hospital, is the key to a successful treatment. Another challenge 
to avoid is long delay times of transportation between hospitals, 
as it is associated with worse clinical outcome and diminished 
advantage of primary PCI over thrombolytic therapy.
P R I M A R y  P C I  D e L A y  T I M e S -
D e F I N I T I O N S
The goal of treatment for patients with chest pain onset 
of less than 12 hours and persistent ST segment elevation or 
(presumed) new left bundle branch block is mechanical or 
pharmaceutical reperfusion of the infarct-related coronary 
artery with a thrombolysis in myocardial infarction (TIMI) 
3 flow and myocardial blush grade 3 achieved as soon as 
possible.7 Time from onset of symptoms to restoration of 
vessel patency is defined as total ischemic time which can be 
subdivided into time from symptom onset to first medical 
contact (FMC) and time from FMC (either ambulance crew 
or PCI capable hospital or non-PCI capable hospital) to bal-
loon inflation (door-to-balloon) or time from symptom onset 
to administration of thrombolytic therapy (door-to-needle). 
PCI related time is the difference between the door-to-balloon 
minus the door-to-needle time. From randomized trials it 
was calculated that PCI-related time delay that can decrease 
the effectiveness of mechanical restoration of vessel patency 
over thrombolysis varies between 60 and 110 min.8,9 Pinto et 
al10 calculated the mean PCI-related time delay where two 
reperfusion strategies have equal mortality rates and that time 
was 114 min. However, this time delay varies according to age, 
time from symptom onset and infarct location. For example 
a patient <65 years old, with an anterior myocardial infarc-
tion presenting early (<2 hours from symptom onset) should 
undergo primary PCI within <1 hour, while for a patient >65 
years old, with inferior infarction and presentation >2 hours 
after symptom onset, PCI related time could reach 3 hours.
D O O R - T O - B A L L O O N  T I M e :  
T H e  C R I T I C A L  D e L A y  
A N D  I T S  I M P A C T  O N  O U T C O M e S
Although it seems that patients might have some benefit 
from reperfusion even after long delays including improved 
ventricular remodeling and less susceptibility to arrhythmias,11 
the longer the total ischemic time and duration of vessel occlu-
sion, the greater the necrosis of the myocardium.12 However, 
the impact on mortality of total ischemic time is often difficult 
to assess, because the part of time from symptom onset to 
hospital admission is based on patient’s sometimes conflict-
ing estimations and thus cannot be independently verified. In 
contrast, door-to-balloon times are usually more accurately 
recorded. Several studies indicate that any delay after hospital 
admission to balloon inflation is associated with worse outcome 
and higher mortality. In the GUSTO-IIb trial, 30-day mortal-
ity was increased with increasing time from randomization 
to balloon inflation.13 Brodie et al14 in a study cohort of 2300 
patients indicated that in-hospital mortality was significantly 
higher with prolonged door-to-balloon times (0 to 1.4 h vs 1.5 
to 1.9 h vs 2.0 to 2.9 h vs ≥3 h), with in-hospital mortality rate 
(4.9% vs 6.1% vs 8% vs 12.2% respectively, p<0.0001). Pro-
longed door-to-balloon times (0 to 1.4 h vs 1.5 to 1.9 h vs 2.0 
to 2.9 h vs ≥3 h) were also associated with higher late mortal-
ity (12.6% vs 16.4% vs 20.4% vs 27.1% respectively at 7 years 
p<0.0001). According to classification in high and low risk 
patients presenting with STEMI, the impact on late mortality 
of delayed (≥2 h vs ≤2 h) door-to-balloon times was greater in 
high risk patients (32.5% vs 21.5% at 7 years, p=0.0002) and 
early (≤3 h) compared to late presenters (24.7% vs 15.0% at 7 
years, p=0.0001). High risk patients were defined as patients 
with Killip class 3 or 4, age >70 years or anterior infarction. 
Unfortunately high risk patients along with women and dia-
betics were more likely to have longer door-to-balloon times. 
McNamara et al15 in a cohort study including 29222 patients, 
indicated that longer door-to-balloon time was associated with 
increased in-hospital mortality (mortality rate of 3.0%, 4.2%, 
7% and 7.4% for door-to-balloon times of ≤90 min, 91 to 120 
min, 121 to 150 min and >150 min respectively, p<0.001). 
Increasing mortality with increasing door-to-balloon time was 
independent from time from symptom onset to presentation or 
presence of high risk factors. On the same wavelength, Rathore 
et al16 in a large cohort study of 43801 patients indicated that 
longer door-to-balloon times were associated with higher 
risk of in-hospital mortality (mortality rate 3.0% for 30 min, 
3.5% for 60 min, 4.3% for 90 min, 5.6% for 120 min, 7% for 
150 min and 8.4% for 180 min p<0.001) suggesting that time 
to treatment should be as short as possible, even in centers 
capable of performing primary PCI within 90 min (absolute 
reduction in mortality 0.8% for reduction from 90 to 60 min). 
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R e P e R F U S I O N  S T R A T e G I e S  
A N D  I M P R O v e M e N T  
I N  D O O R – T O – B A L L O O N  T I M e S
The European Society of Cardiology (ESC) guidelines 
indicate the preferred pathway17 of treating STEMI patients. 
Patients referred to a PCI capable center should immediately 
undergo primary PCI by a team of high volume operators, 
while patients admitted to non PCI capable hospital should be 
transferred to a PCI capable hospital if time delay from FMC 
to balloon inflation is <2 h, or <90 min for patients with large 
anterior infarction, <75 years old and recent (<2 h) onset of 
symptoms. If primary PCI cannot be achieved within these 
time limits, the patient should receive fibrinolysis immediately 
(door-to-needle <30 min) and then be transferred to a PCI 
capable hospital in order to undergo angiography and rescue 
PCI in case of failed fibrinolysis, or angiography and delayed 
PCI if required, in case of successful fibrinolysis, in a time 
window of 3-24 hours. According to ACC/AHA guidelines, 
75% of STEMI patients should undergo primary PCI within 90 
min.18 However, this task is not always easy to achieve. There 
are two key points for successful reperfusion with primary PCI: 
a) short delay times and b) a cardiac catheterization laboratory 
available 24 hours/7 days including experienced interventional 
cardiologists and supporting staff. 
Despite the fact that better patient education about 
symptoms indicating myocardial infarction (in order to seek 
medical help as soon as possible) could minimize the time from 
symptom onset to FMC and consequently the total ischemic 
time, reduction of time delays in health care systems including 
transportation delay and door-to-balloon time, is the main 
target in order to achieve lower rates of in-hospital and late 
mortality. For this purpose, not only a well organized medi-
cal system is mandatory, but also a well functioning network 
of centers for safe and rapid STEMI patient transportation. 
Μiedema et al19 indicated that the greater delays from FMC 
at the referral hospital until arrival at the catheterization 
laboratory are observed when there is diagnostic dilemma, 
non-diagnostic ECG, hemodynamic compromise or bad 
weather conditions. In this particular study19 of 2034 pa-
tients transferred for primary PCI, the authors reported the 
frequency, magnitude and clinical impact of specific delays. 
Each patient’s total door-to-balloon time (arrival at referral 
hospital to balloon at PCI center) was divided into three seg-
ments: referral hospital door–in to door-out time, transport 
time and PCI center door-to-balloon time, with a delay limit 
of 45-45-30 minutes respectively, and a targeted total door-
to-balloon time of 120 minutes. Οf the above patients 30.4% 
were treated with pPCI in ≤90 min and 65.7% in ≤120 min. 
The most frequent delay was at the referral hospital (64% of 
the patients) followed by the PCI center (15.7%) and transport 
(12.6%).The most common reasons for delay at the referral 
hospital were awaiting transport and emergency department 
delay. Diagnostic dilemmas and non diagnostic ECG were 
the delays of the greatest magnitude, while delays caused by 
cardiogenic shock had the highest mortality. According to our 
own experience the main causes of inter-hospital and door-
to-balloon time delays in our health system are summarized 
in Table 1 and discussed in detail below. Data from the Na-
tional Registry for Myocardial Infarction (NRMI)20 indicated 
that inter-hospital transfer from a non-PCI to a PCI-capable 
hospital is associated with low rates of door-to-balloon within 
time limits (4.2% for door-to-balloon <90 min, 16.2% for 
door-to-balloon <2 h). It is not surprising that Wang et al21 
indicated that STEMI patients requiring inter-hospital transfer 
for primary PCI had longer door-to-balloon times in com-
parison with direct arrival STEMI patients (median 149 vs 79 
min p<0.001) and few received PCI at ≤90 min (10% vs 63% 
p<0.001). Very recently Pinto et al22 reported that PCI-related 
delays are extensive among patients transferred for pPCI and 
are associated with poorer outcomes. As pPCI was performed 
with delays >90 minutes in 68% of transferred patients, there 
was no difference in mortality (5.7% vs 6.1%), in the composite 
end-point of death or myocardial infarction (6.7% vs 8.6%) 
and death, myocardial infarction or stroke (7.1% vs 9.3%), but 
the rate of in-hospital stroke was lower with pPCI (0.7% vs 
1.8%) versus on-site thrombolysis; these results indicate the 
need for decreasing health care system delay by eliminating 
inter-hospital delay. Brown et al23 indicated that pre-hospital 
diagnosis of STEMI with 12-lead electrocardiogram (ECG) 
and immediate pre-hospital activation of cardiac catheter-
ization laboratory is associated with significant reduction in 
door-to-balloon time (73±19 min field STEMI, 130±66 min 
non-field STEMI, 141±49 min historical STEMI; p<0.001). 
Rokos et al24 indicated that pre-hospital 12-lead ECG STEMI 
diagnosis and direct transportation to a PCI-capable hospital 
without any delay related to transportation to a non-PCI 
capable hospital and then inter-hospital transfer, achieved 
a door-to-balloon time of ≤90 min in 86% of patients. Also 
Dieker et al25 showed that after ambulance-based diagnosis of 
STEMI, direct transportation to an intervention center with 
pre-hospital notification of the catheterization laboratory 
increases more than 3-fold the proportion of patients treated 
within the time window of the guidelines.. Finally according 
to Postma et al,26 pre-hospital triage in the ambulance, re-
TABLe 1. Major Causes of Specific Delays Associated With 
Door-to-Balloon Times in Greece
1. Awaiting transport (>60% of cases)
2. Prolonged time from symptom to first medical contact
3. Long distance, particularly in island population
4. Weather conditions in air- or by sea transport
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duces time to treatment, infarct size and improves outcome 
especially for patients living at a long distance from the PCI 
center. Other key elements for reduction of door-to-balloon 
times that have been proposed include enabling of emergency-
medicine physician to activate the catheterization laboratory 
without gaining approval from a cardiologist, or activation of 
the catheterization laboratory from an attendant cardiologist. 
Unnecessary intermediate admissions in the emergency room 
or the intensive care unit in PCI-capable centers should also 
be avoided. A drawback of primary PCI is that presentation 
during off-hours is common and seems to be associated with 
longer times to treatment. In contrast, off-hours presentation 
does not affect fibrinolytic therapy.27
According to ACA/AHA Guidelines, primary PCI should 
be performed by interventional cardiologists with high volume 
of such procedures (>75 elective per year and at least 11 for 
STEMI), in hospitals with an annual volume of >400 elective 
and >36 primary PCI procedures28. Recently, Krumholtz et 
al29 presented data from a registry which included all patients 
undergoing primary PCI reported by hospitals to the centers 
for Medicare and Medical services in USA and demonstrated 
that door-to-balloon time declined from a median of 96 min 
in 2005 to a median of 64 min in 2010. There was correspond-
ing increasing percentage of patients who had times <90 min 
(44.2% to 91.4%) and <75 min (27.3% to 70.4). These data 
indicate that significant improvement in door-to-balloon times 
has been achieved. Finally, significant advances in antithrom-
botic agents, including new antiplatelet agents with more rapid 
onset and stronger inhibition of platelet activity (prasugrel and 
ticagrelor), in combination with manual thrombus aspiration 
from the culprit lesion have a positive impact on successful 
mechanical reperfusion and outcome of STEMI patients. 
With regards to Greece, official data concerning door-
to-balloon time were recently presented by J. Kanakakis30 
(principal investigator for Greece), in the European meeting 
for the Stent for Life program. According to these data, the 
door-to-balloon time in our country is 63 min, almost identi-
cal with the one of 64 min reported by Krumholtz et al.29 
However, time from symptom to first medical contact (182 
min) and time from first medical contact to balloon (142 
min) remain, unfortunately, still prolonged. In general terms, 
regarding the implementation of the program Stent for Life 
in Greece, a significant improvement from August 2009 until 
today has been reported, in the rates of pPCI for the treatment 
of acute myocardial infarction. In particular, while in 2009 
rates of pPCI were 9%, those of intravenous thrombolysis 
41% and no reperfusion 50% for the total of patients with 
STEMI, those for 2011 are 32%, 40% and 28% respectively. 
In absolute terms the number of pPCIs in 2009 increased by 
95/1.000.000 inhabitants (i.e. 1491 for the whole country) to 
346/1.000.000 inhabitants (i.e. 3733 for the whole country) in 
2011. The most important increase occurred in the metro-
politan area of the capital, where the proportion of patients 
treated with pPCI rose from 31% to 59%, very close to the 
desired objective of 70%. The same registry demonstrated 
a mortality rate of 4.7% with pPCI, 5.7% with intravenous 
thrombolysis, 10% with rescue angioplasty and 11% when 
no reperfusion occurs.30 Despite these very encouraging and 
positive early data, problems remain in the setting of pPCI 
in insular Greece and in the response time of the emergency 
medical system (EMS-EKAB) for inter-hospital transfers. 
Although, the various urban, suburban and rural areas of 
the country, are indeed adequately covered by existing cath-
eterization laboratories, there are still major problems for 
insular Greece, given also the difficulties in air-transports. 
Regarding system transfer delays, it remains problematic 
because of the exceptional difficulties of successful response 
times from the staff of EMS-EKAB (drivers-paramedics-
administrators), when it comes to transporting a patient who 
arrived to a hospital without catheterization facilities to a 
PCI center or when a patient with diagnosed STEMI is, by 
administration procedures, directed to a hospital without a 
catheterization laboratory. Improved however (as mentioned 
above) are the response times, when EMS-EKAB is called 
directly by the patient or his/her relatives on-site for transfer 
of the suspected patient with STEMI to the appropriate hos-
pital. Satisfactory solutions to these problems may be given 
by the targeted and planned establishment and operation 
of catheterization laboratories in cities, which may better 
cover today’s existing gaps. For example, new catheteriza-
tion laboratories could open up in Tripoli or Kalamata for 
south-center Peloponnese, thus not streaming to Patras the 
whole traffic of STEMI patients for the entire Peloponnese; 
similarly a second catheterization laboratory can open up in 
Chania for Western Crete and relieve the load directed to 
Heraklion now serving the entire Crete; other places for new 
catheterization facilities may include Kavala for the axis of 
Thessaloniki-Alexandroupoli of Eastern Macedonia, Veria 
for Western Macedonia, Volos to assist Larissa for Thessaly, 
and Lamia or Chalkida for Central Greece. 
With regards to a more appropriate response of the emer-
gency system transport, positive results may be obtained by 
pre-hospital ECG diagnosis of STEMI (even via-telemedicine) 
and triage in the ambulance, direct transportation to a PCI-
capable center without unnecessary admittance to a non-PCI 
capable hospital, pre-hospital activation of the catheterization 
laboratory before the patient’s arrival in order to bypass the 
emergency department and the presence of high volume op-
erators and skilled supporting staff available 24 hours/7 days. 
Nevertheless the dominant role, which will largely contribute 
and determine the success of the whole procedure to decrease 
as low as possible the door-to-balloon time, is the change of 
bureaucratic mentality, that still dominates a vast majority of 
professionals involved in our health system.
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In conclusion, it is an established knowledge that door-
to-balloon time delay is associated with increased mortality 
in STEMI patients undergoing primary PCI. Thus, reducing 
this time delay to the greatest extent possible for all patients, 
including those currently treated within 90 min, might reduce 
mortality. Better patient education about severity of symptoms, 
pre-hospital triage and direct transportation to a PCI center, 
improvements in the organization of the emergency medi-
cal system, wise distribution of PCI centers throughout the 
country, improvements in antithrombotic drugs, angioplasty 
materials and interventional cardiologist’s skills and compe-
tence are the cornerstones for achieving short PCI delay times 
and increase survival.
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